| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.36 | 0.03 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |